Literature DB >> 20425161

The optimal blood pressure target for patients with coronary artery disease.

Paolo Verdecchia1, Fabio Angeli, Claudio Cavallini, Giovanni Mazzotta, Marta Garofoli, Paola Martire, Gianpaolo Reboldi.   

Abstract

None of the available outcome-based studies was primarily designed to compare different blood pressure (BP) goals in patients with coronary artery disease (CAD). Consequently, there is uncertainty about the most appropriate BP treatment goal in these patients. Although US guidelines recommend a target less than 130/80 mm Hg, recent European guidelines state that such aggressive target is not consistently supported, therefore making the case for a less aggressive target (<140/90 mm Hg) in all hypertensive patients including those with CAD. A low systolic BP may be beneficial to limit myocardial workload, but an excessive lowering of diastolic BP might impair coronary perfusion, with potentially adverse effects (J-curve phenomenon). The optimal BP target for patients with CAD remains undefined. A reasonable target appears to be in the range of 130-140/80-90 mm Hg. Any further reduction may be safe, but not much productive from a prognostic standpoint.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425161     DOI: 10.1007/s11886-010-0112-y

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  25 in total

1.  Cardiovascular protection and blood pressure reduction: a meta-analysis.

Authors:  J A Staessen; J G Wang; L Thijs
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

2.  Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.

Authors:  Clive Rosendorff; Henry R Black; Christopher P Cannon; Bernard J Gersh; Joel Gore; Joseph L Izzo; Norman M Kaplan; Christopher M O'Connor; Patrick T O'Gara; Suzanne Oparil
Journal:  Circulation       Date:  2007-05-14       Impact factor: 29.690

3.  Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care.

Authors:  F J Klocke
Journal:  Circulation       Date:  1987-12       Impact factor: 29.690

4.  Re-examination of some of the Framingham blood-pressure data.

Authors:  T W Anderson
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

5.  Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?

Authors:  Franz H Messerli; Giuseppe Mancia; C Richard Conti; Ann C Hewkin; Stuart Kupfer; Annette Champion; Rainer Kolloch; Athanase Benetos; Carl J Pepine
Journal:  Ann Intern Med       Date:  2006-06-20       Impact factor: 25.391

6.  Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis.

Authors:  Ilke Sipahi; E Murat Tuzcu; Paul Schoenhagen; Katherine E Wolski; Stephen J Nicholls; Craig Balog; Timothy D Crowe; Steven E Nissen
Journal:  J Am Coll Cardiol       Date:  2006-06-15       Impact factor: 24.094

Review 7.  The J-curve in hypertension.

Authors:  John Cruickshank
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

8.  Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension.

Authors:  I M Stewart
Journal:  Lancet       Date:  1979-04-21       Impact factor: 79.321

9.  Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.

Authors:  Paolo Verdecchia; Jan A Staessen; Fabio Angeli; Giovanni de Simone; Augusto Achilli; Antonello Ganau; Gianfrancesco Mureddu; Sergio Pede; Aldo P Maggioni; Donata Lucci; Gianpaolo Reboldi
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

10.  The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?

Authors:  L Farnett; C D Mulrow; W D Linn; C R Lucey; M R Tuley
Journal:  JAMA       Date:  1991 Jan 23-30       Impact factor: 56.272

View more
  2 in total

1.  Effects of MPO-463G/A and -129G/A polymorphisms on coronary artery disease risk and patient survival in a Turkish population.

Authors:  Serdal Arslan; Öcal Berkan; Burcu Bayyurt; Osman Beton; Ni L Özbi Lüm Şahin; Eylem Itır Aydemir
Journal:  Biomed Rep       Date:  2017-10-03

Review 2.  Considerations in Understanding the Coronary Blood Flow- Left Ventricular Mass Relationship in Patients with Hypertension.

Authors:  Simon W Rabkin
Journal:  Curr Cardiol Rev       Date:  2017
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.